Location History:
- St. Louis, MO (US) (1998 - 2001)
- Seattle, WA (US) (2005 - 2013)
Company Filing History:
6 out of 2,100 
5 out of 1,582 
2 out of 2 
Years Active: 1998-2013
Title: Jay W Heinecke: Innovator in Cardiovascular Research
Introduction
Jay W Heinecke is a prominent inventor based in Seattle, WA (US). He has made significant contributions to the field of cardiovascular research, holding a total of 11 patents. His work focuses on innovative methods and compositions that address cardiovascular diseases and cholesterol management.
Latest Patents
One of his latest patents is for a mutant apolipoprotein A-1 polypeptide with increased resistance to oxidation and reactive carbonyls. This invention provides isolated oxidation-resistant mutant apoA-I polypeptides that include specific amino acid substitutions, making them resistant to modification by oxidizing agents. Additionally, Heinecke has developed methods and compositions for the diagnosis or prognosis of cardiovascular disease. This invention involves screening methods that detect biomarkers in a biological sample to assess the risk of cardiovascular disease in subjects.
Career Highlights
Heinecke has worked with esteemed institutions such as the University of Washington and Washington University. His research has significantly advanced the understanding of cardiovascular health and the role of apolipoproteins in cholesterol metabolism.
Collaborations
Some of his notable coworkers include Tomas Vaisar and Bryan Prazen. Their collaborative efforts have contributed to the development of innovative solutions in cardiovascular research.
Conclusion
Jay W Heinecke's contributions to cardiovascular research through his patents and collaborations highlight his role as a leading inventor in the field. His work continues to impact the understanding and treatment of cardiovascular diseases.